加载中
NYSEHealthcareMedical - Diagnostics & Research
最新数据
US$253.44
−US$4.675 · -1.81%
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.
常规交易时段
US$253.44
−US$4.675 · -1.81%
盘中时间采用ET。市场数据可能有所延迟。
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.
日内区间
当前US$253.44
52周区间
当前US$253.44
盘中时间采用ET。市场数据可能有所延迟。
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.
日内区间
当前US$253.44
52周区间
当前US$253.44
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 163.1亿 USD | 154.05亿 USD | 149.84亿 USD | 144.1亿 USD | 138.74亿 USD |
| 销货成本 | 108.8亿 USD | 100.3亿 USD | 97.45亿 USD | 93.82亿 USD | 92.33亿 USD |
| 毛利 | 54.3亿 USD | 53.75亿 USD | 52.39亿 USD | 50.28亿 USD | 46.41亿 USD |
| 销售、一般及管理费用 | 19.88亿 USD | 19.92亿 USD | 20.53亿 USD | 20.71亿 USD | 19.64亿 USD |
| 营业费用 | 32.48亿 USD | 31.73亿 USD | 32.62亿 USD | 32.29亿 USD | 32.48亿 USD |
| 利息收入 | 4500万 USD | 4700万 USD | 3600万 USD | 1300万 USD | 600万 USD |
| 利息支出 | 7.29亿 USD | 6.7亿 USD | 6.72亿 USD | 4.16亿 USD | 3.75亿 USD |
| 折旧和摊销 | 6.4亿 USD | 11.14亿 USD | 11.25亿 USD | 11.3亿 USD | 12.64亿 USD |
| 营业利润 | 21.82亿 USD | 22.02亿 USD | 19.77亿 USD | 17.99亿 USD | 13.93亿 USD |
| 净利润 | 13.6亿 USD | 13.73亿 USD | 13.58亿 USD | 10.91亿 USD | 9.66亿 USD |
公司数据更新于 2026年10月8日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
报告持有此股票敞口的交易所交易基金。
State Street SPDR S&P 500 ETF1557.T820.43亿0.06%129.41万亿 JPY0.09%JP¥122,700-0.57%
Vanguard Morningstar Total Stock Market ETFVTI13.86亿0.06%2.3万亿 USD0.03%US$379.8-0.32%
Vanguard S&P 500 ETFVOO11.57亿0.07%1.8万亿 USD0.03%US$712.15-0.31%
Vanguard Morningstar Mid-Cap ETFVO9.43亿0.42%2264亿 USD0.03%US$79.84-0.37%
iShares Core S&P 500 ETFIVV5.65亿0.06%8996.25亿 USD0.03%US$778.2-0.30%
State Street SPDR S&P 500 ETFSPY5.18亿0.06%8190.39亿 USD0.09%US$774.76-0.32%
Vanguard Morningstar Value ETFVTV4.17亿0.16%2624亿 USD0.03%US$217.82-0.18%
State Street Health Care Select Sector SPDR ETFXLV3.04亿0.70%431.09亿 USD0.08%US$167.16-0.98%State Street SPDR S&P 500 ETF1557.TVanguard Morningstar Total Stock Market ETFVTIVanguard S&P 500 ETFVOOVanguard Morningstar Mid-Cap ETFVOiShares Core S&P 500 ETFIVVState Street SPDR S&P 500 ETFSPYVanguard Morningstar Value ETFVTVState Street Health Care Select Sector SPDR ETFXLVAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
